THE ROBERT H. LURIE Comprehensive Cancer Center of Northwestern University, the Northwestern Medicine Developmental Therapeutics Institute, and NeoGenomics Inc. entered into a research agreement with plans to initiate a translational program focused on expanding the use of genomic profiling technologies.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
